Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria

British Journal of Pharmacology

Volumn 138, Issue 2, 2003, Pages 369-376

  Simon, Nicolas ^a   Morin, Christophe ^b   Urien, Saïk ^b   Tillement, Jean Paul ^b   Bruguerolle, Bernard ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

FK506; Mitochondria; Oxidative phosphorylation; Rapamycin; Sirolimus; Tacrolimus

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CYCLOSPORIN A; CYTOCHROME C; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TACROLIMUS; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MALE; MEMBRANE FLUIDITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NEPHROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ANIMALS; KIDNEY; MALE; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR; SIROLIMUS; TACROLIMUS;

EID: 0344520487     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705038     Document Type: Article

References (31)

1. ANDOH, T.F., LINDSLEY, J., FRANSECHINI, N. & BENNETT, W.M. (1996). Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation, 62, 311-316.
2. BROEKEMEIER, K. & PFEIFFER, D.R. (1995). Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. Biochemistry, 34, 16440-16449.
3. DE MATTOS, A.M., OLYAEI, A.J. & BENNETT, W.M. (2000). Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am. J. Kidney Dis., 35, 333-346.
4. FISKE, C.H. & SUBBAROW, Y. (1925). The colorimetric determination of phosphorus. J. Biol. Chem., 66, 1225-1230.
5. FRIBERG, H., FERRAND-DRAKE, M., BENGTSSON, F., HALESTRAP, A.P. & WIELOCH, T. (1998). Cyclosporin A, but not FK506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci., 18, 5151-5159.
6. GABE, S.M., BJARNASON, I., TOLOU-GHAMARI, Z., TREDGER, J.M., JOHNSON, P.G., BARCLAY, G.R., WILLIAMS, R. & SILK, D.B.A. (1998). The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology, 115, 67-74.
7. GUMMERT, J.F., IKONEN, T. & MORRIS, R.E. (1999). Newer immunosuppressive drugs: a review. J. Am. Soc. Nephrol., 10, 1366-1380.
8. HALESTRAP, A.P. & DAVIDSON, A.M. (1990). Inhibition of Ca2(+)induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J., 268, 153-160.
9. HENKE, W. & JUNG, K. (1993). Comparison of the effects of the immunosuppressive agents FK 506 and cyclosporin A on rat kidney mitochondria. Biochem. Pharmacol., 46, 829-832.
10. MADSEN, K.L., YANCHAR, N.L., SIGALET, D.L., REIGEL, T. & FEDORAK, R.N. (1995). FK506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology, 109, 107-114.
11. MASSICOT, F., MARTIN, C., DUTERTRE-CATELLA, H., ELLOUKACHARD, S., PHAM-HUY, C., THEVENIN, M., RUCAY, P., WARNET, J.M. & CLAUDE, J.R. (1997). Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line. Arch. Toxicol., 71, 529-531.
12. MECOCCI, P., BEAL, M.F., CECCHETTI, R., POLIDORI, M.C., CHERUBINI, A., CHIONNE, F., AVELLINI, L., ROMANO, G. & SENIN, U. (1997). Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol. Chem. Neuropathol., 31, 53-64.
13. MEIER-KRIESCHE, H.-U. & KAPLAN, B. (2000). Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations. Clin. Ther., 22, B93-B100.
14. MORALES, J.M., ANDRES, A., RENGEL, M. & RODICIO, J.L. (2001). Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. Nephrol. Dial. Transplant., 16 (Suppl. 1): 121-124.
15. MORIN, C., ZINI, R., SIMON, N., CHARBONNIER, P., TILLEMENT, J.P. & LE LOUET, H. (2000). Low glucocorticoid concentrations decrease oxidative phosphorylation of isolated rat brain mitochondria: an additionnal effect of dexamethasone. Fundam. Clin. Pharmacol., 14, 493-500.
16. PELEKANOU, V., TREZISE, A.E., MOORE, A.L. & KAY, J.E. (1991). FK506 and rapamycin do not affect platelet aggregation or mitochondrial function. Transplant. Proc., 23, 3200-3201.
17. PODDER, H., STEPKOWSKI, S.M., NAPOLI, K.L., CLARK, J., VERANI, R.R., CHOU, T.C. & KAHAN, B.D. (2001). Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J. Am. Soc. Nephrol., 12, 1059-1071.
18. PRASAD, S.J., MCCAULEY, J., SALAMA, G., STARZL, T.E. & MURRAY, S.A. (1991). In vitro effects of cyclosporine and FK 506 on the renal cortex. Transplant. Proc., 23, 3128-3129.
19. 2+ influx in endoplasmic reticulum: a comparison with mitochondria. Biochem. J., 338, 221-227.
20. RICCHELLI, F., GOBBO, S., JORI, G., SALET, C. & MORENO, G. (1995). Temperature-induced changes in fluorescence properties as a probe of porphyrin microenvironment in lipid membranes. 2. The partition of hematoporphyrin and protoporphyrin in mitochondria. Eur. J. Biochem., 233, 165-170.
21. RICCHELLI, F., GOBBO, S., MORENO, G.N. & SALET, C. (1999b). Changes of the fluidity of mitochondrial membranes induced by the permeability transition. Biochemistry, 38, 9295-9300.
22. RICCHELLI, F., JORI, G., GOBBO, S. & TRONCHIN, M. (1991). Liposome as models to study the distribution of porphyrins in cell membranes. Biochim. Biophys. Acta., 1065, 42-48.
23. RUSTIN, P., CHRÉTIEN, D., BOURGERON, T., GÉRARD, B., ROTIG, A., SAUDUBRAY, J.M. & MUNNICH, A. (1994). Biochemical and molecular investigations in respiratory chain deficiences. Clin. Chim. Acta, 228, 35-51.
24. SAUNDERS, R.N., METCALFE, M.S. & NICHOLSON, M.L. (2001). Rapamycin in transplantation: a review of the evidence. Kidney Int., 59, 3-16.
25. SERKOVA, N., JACOBSEN, W., NIEMANN, C.U., LITT, L., BENET, L.Z., LEIFRITZ, D. & CHRISTIANS, U. (2001). Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br. J. Pharmacol., 133, 875-885.
26. SIMON, N., JOLLIET, P., ZINI, R., MORIN, C., URIEN, S. & TILLEMENT, J.P. (1998). Glucocorticoids decrease cytochrome c oxidase activity of isolated rat kidney mitochondria. FEBS Lett., 435, 25-28.
27. SIMON, N., ZINI, R., MORIN, C., BRÉE, F. & TILLEMENT, J.P. (1997). Prednisolone and azathioprine worsen the cyclosporine A-induced oxidative phosphorylation decrease of kidney mitochondria. Life Sci., 61, 659-666.
28. SPENCER, C.M., GOA, K.L. & GILLIS, J.C. (1997). Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs, 54, 925-975.
29. URIEN, S. (1995). MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes. Pharm. Res., 12, 1225-1230.
30. VEITCH, K., HOMBROECKX, A., CAUCHETEUX, D., POULEUR, H. & HUE, L. (1992). Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochem. J., 281, 709-715.
31. ZINI, R., SIMON, N., MORIN, C., THIAULT, L. & TILLEMENT, J.P. (1998). Tacrolimus decreases in vitro oxidative phosphorylation of mitochondria from rat forebrain. Life Sci., 63, 357-368.